The increasing prevalence of patients who require frequent hospital admissions is fostering growth of the Europe Viscosupplementation market

 

Europe Viscosupplementation Market

The Europe Viscosupplementation market segments include single dose, delayed onset of action (DAA) capsules, sustained-release capsules, and multiple-dose vial products. Based on therapeutic product type, the European market is further divided into single injection, three-dose, and five-dose capsules. Single-dose capsules are recommended to be used as an immediate relief for allergic rhinitis and may provide significant clinical improvement, while three or five-dose capsules are recommended for patients with mild to moderate chronic rhinitis and provide significant clinical improvement. For patients who have moderate to severe persistent sinusitis it is not recommended due to the slow elimination phase associated with the product and prolonged release of medications in the body.

The increasing prevalence of patients who require frequent hospital admissions and long periods of operative management can be expected to result in a dramatic increase in the Europe Viscosupplementation market over the forecast period. The growing popularity of the single-dose regime can be attributed to the ease of administration, consistent delivery system, and adequate pain relief. The single-dose capsules are usually manufactured in single batches and delivered to the patients in accordance with the manufacturing instructions. The three and five-dose capsules can be manufactured in volume quantities and are often shipped in refrigerated conditions for longer shelf life. Single-dose and three and five-dose options are currently being marketed across Europe.

Eastern and Western Europe viscosupplementation market sectors are expected to experience strong growth in the coming years, driven primarily by the increasing number of new patients. In addition, the aging population in Eastern Europe is contributing to the high level of health-related costs. As per the recent trends in the pharmaceutical industry, the demand for safe and effective drugs is increasing in Europe. The availability of the single-dose capsule is another factor that has played a key role in encouraging more patients to adopt this drug as an alternative treatment option.


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

The North America Vision Care Market Is Driven by the Increasing Prevalence of Eye Diseases in this Region